These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17479486)

  • 1. Case 40-2006: anemia and low HDL cholesterol.
    Goldberg RB; Mendez AJ
    N Engl J Med; 2007 May; 356(18):1893-5; author reply 1893-5. PubMed ID: 17479486
    [No Abstract]   [Full Text] [Related]  

  • 2. Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein.
    Tsai LY; Tsai SM; Lee SC; Liu SF
    Clin Chim Acta; 2005 Aug; 358(1-2):192-5. PubMed ID: 15896728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case records of the Massachusetts General Hospital. Case 40-2006. A 64-year-old man with anemia and a low level of HDL cholesterol.
    Murali MR; Kratz A; Finberg KE
    N Engl J Med; 2006 Dec; 355(26):2772-9. PubMed ID: 17192544
    [No Abstract]   [Full Text] [Related]  

  • 4. Case 40-2006: anemia and low HDL cholesterol.
    Schifferli JA
    N Engl J Med; 2007 May; 356(18):1893-5; author reply 1893-5. PubMed ID: 17476023
    [No Abstract]   [Full Text] [Related]  

  • 5. Look before you leap (treat): severely low high-density lipoprotein cholesterol.
    McNamara DA; Patel RB; Stone NJ
    Am J Med; 2013 Feb; 126(2):e1-2. PubMed ID: 23331450
    [No Abstract]   [Full Text] [Related]  

  • 6. Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia.
    van Gorselen EO; Diekman T; Hessels J; Verhorst PM; von Birgelen C
    Clin Res Cardiol; 2010 Sep; 99(9):599-602. PubMed ID: 20593189
    [No Abstract]   [Full Text] [Related]  

  • 7. Paraprotein interferences in routine laboratory assays.
    Sulaiman R; Othonos N; Gama R
    Pathology; 2011 Jan; 43(1):86. PubMed ID: 21240079
    [No Abstract]   [Full Text] [Related]  

  • 8. Polyclonal hypergammaglobulinaemia interference in serum HDL-C assays.
    Griffiths MJ; Jahagirdar VR; Fernando J; Gama R
    Clin Lab; 2008; 54(3-4):95-6. PubMed ID: 18630739
    [No Abstract]   [Full Text] [Related]  

  • 9. Paraproteins are a common cause of interferences with automated chemistry methods.
    Yang Y; Howanitz PJ; Howanitz JH; Gorfajn H; Wong K
    Arch Pathol Lab Med; 2008 Feb; 132(2):217-23. PubMed ID: 18251580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.
    Komori H; Arai H; Kashima T; Huby T; Kita T; Ueda Y
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1298-303. PubMed ID: 18403724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low HDL cholesterol levels.
    Xie Y; Davidson NO
    N Engl J Med; 2006 Jan; 354(4):417-9; author reply 417-9. PubMed ID: 16444811
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo metabolism of a monoclonal IgG cryoglobulin.
    Abraham GN; Waterhouse C; Condemi JJ
    Clin Exp Immunol; 1979 Jan; 35(1):89-95. PubMed ID: 428148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapies for raising HDL cholesterol beyond synthetic small molecules.
    Garcia RA
    Curr Opin Investig Drugs; 2008 Mar; 9(3):274-80. PubMed ID: 18311663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
    Walldius G; Jungner I
    Curr Opin Cardiol; 2007 Jul; 22(4):359-67. PubMed ID: 17556890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
    Carreón-Torres E; Rendón-Sauer K; Monter-Garrido M; Toledo-Ibelles P; Gamboa R; Menjivar M; López-Marure R; Luc G; Fievet C; Cruz D; Vargas-Alarcón G; Pérez-Méndez O
    Clin Chim Acta; 2009 Mar; 401(1-2):37-41. PubMed ID: 19036342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C reactive protein: a band mistaken as monoclonal gammapathy in acute inflammatory disease.
    Jacquiaud C; Bastard JP; Delattre J; Jardel C
    Ann Med Interne (Paris); 1999 Jun; 150(4):357-8. PubMed ID: 10519023
    [No Abstract]   [Full Text] [Related]  

  • 18. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glucosamine on Serum HDL cholesterol and apolipoprotein AI levels in people with diabetes.
    Albert SG; Oiknine RF; Parseghian S; Mooradian AD; Haas MJ; McPherson T
    Diabetes Care; 2007 Nov; 30(11):2800-3. PubMed ID: 17682119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.